RNA Details
Disease Name
idiopathic pulmonary fibrosis
Tissue
lung
RNA Symbol
PTGS2
RNA ID
5743
RNA Type
mRNA
Alteration Pattern
histone hypermethylation
Species
homo sapiens
Detection Methods
qRT-PCR; ELISA etc.
Target
NA
Pathway
NA
PubMed ID
24652950
Title
A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis
Year
2014
Function
"Marked increases in H3K9me3, H3K27me3, and DNA methylation, together with their respective modifying enzymes G9a, EZH2, and DNA methyltransferases (Dnmts) and respective binding proteins heterochromatin protein 1 (HP1), polycomb protein complex 1 (PRC1) and methyl CpG binding protein 2 (MeCP2), at the COX-2 promoter in lung fibroblasts from patients with IPF (F-IPFs) can induce COX-2 expression silence. G9a and EZH2 and the Dnmt1 inhibitor markedly reduced H3K9me3 (49-79%), H3K27me3 (44-81%), and DNA methylation (61-97%) at the COX-2 promoter. These reductions were correlated with increased histone H3 and H4 acetylation, resulting in COX-2 mRNA and protein reexpression in F-IPFs."
RNA Details
Disease Name
idiopathic pulmonary fibrosis
Tissue
lung
RNA Symbol
PTGS2
RNA ID
5743
RNA Type
mRNA
Alteration Pattern
dna methylation
Species
homo sapiens
Detection Methods
qRT-PCR; ELISA etc.
Target
NA
Pathway
NA
PubMed ID
24652950
Title
A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis
Year
2014
Function
"Marked increases in H3K9me3, H3K27me3, and DNA methylation, together with their respective modifying enzymes G9a, EZH2, and DNA methyltransferases (Dnmts) and respective binding proteins heterochromatin protein 1 (HP1), polycomb protein complex 1 (PRC1) and methyl CpG binding protein 2 (MeCP2), at the COX-2 promoter in lung fibroblasts from patients with IPF (F-IPFs) can induce COX-2 expression silence. G9a and EZH2 and the Dnmt1 inhibitor markedly reduced H3K9me3 (49-79%), H3K27me3 (44-81%), and DNA methylation (61-97%) at the COX-2 promoter. These reductions were correlated with increased histone H3 and H4 acetylation, resulting in COX-2 mRNA and protein reexpression in F-IPFs."